Arrowhead Pharmaceuticals Inc.
ARWR | NASDAQ
$68.79
+$2.31 (+3.47%)
At close: Sep 21, 2026, 4:00 PM ET
$68.51
-$0.28 (-0.41%)
After-hours:
Sep 21, 2026, 7:36 PM ET
Market Data
Market Cap $9.36B
Enterprise Value $8.95B
Beta 1.28
Average Volume 1.89M
Shares Outstanding (Diluted) 143.38M
Shares Change YoY 3.12%
Institutional Ownership 84.84%
Exchange NASDAQ
ISIN US04280A1007
Price Performance
Price Change 1M -20.7%
Price Change 3M -13.9%
Price Change 6M 13.2%
Price Change YTD 1.5%
Price Change 1Y 114.6%
Price Change 3Y 152.5%
Price Change 5Y 5.2%
1M CAGR (ann.) -22.5%
1Y CAGR (ann.) 128.2%
5Y CAGR (ann.) 0.8%
All-Time CAGR 1.4%
Valuation
PE Ratio -30.71
Forward PE N/A
PEG Ratio 0.00
Forward PEG -0.95
PS Ratio 14.47
Forward PS 28.20
PB Ratio 20.81
P/FCF Ratio -129.00
P/Adj. FCF Ratio -66.77
P/OCF Ratio -167.78
EV/Sales 13.37
EV/EBIT -56.13
EV/EBITDA -63.79
EV/FCF -119.18
Earnings Yield -3.3%
FCF Yield -0.8%
Adj. FCF Yield -1.5%
Financial Health
Net Cash $737.89M
Total Debt $864.07M
Cash & Short-Term Investments $1.6B
Total Assets $2.11B
Current Ratio 5.90
Quick Ratio 5.90
Debt / Equity Ratio 1.86
Debt / EBITDA -6.16
Debt / FCF -11.50
OCF / Debt -0.07
Interest Coverage -2.45
Altman Z-Score 3.00
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -33.8%
EBITDA Margin -21.0%
Net Profit Margin -47.8%
FCF Margin -11.2%
Adj. FCF Margin -21.7%
SBC / Revenue 10.5%
SBC Impact (per share) -93.2%
Returns
Return on Assets -15.2%
Return on Equity -60.5%
Return on Invested Capital -12.1%
Return on Capital Employed -12.4%
Return on Tangible Assets -15.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 37.7%
Revenue CAGR 5Y 44.1%
Revenue CAGR 10Y 128.7%
EPS CAGR 3Y 44.3%
EPS CAGR 5Y -5.0%
EPS CAGR 10Y -21.8%
FCF CAGR 3Y 109.7%
FCF CAGR 5Y 19.0%
FCF CAGR 10Y -29.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 22
EPS Growth Next 3Y 22.3%
Revenue Growth Next 3Y 19.7%
Earnings Date Nov 23, 2026
EPS Estimate (next Q) -$1.59
EPS Growth Est (next Q) 783.3%
Revenue Est (next Q) $59.43M
Revenue Growth Est (next Q) -76.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $104.43
Price Target Upside 51.8%
Cash Flow
Operating Cash Flow $-59.06M
Free Cash Flow $-75.11M
Adj. Free Cash Flow $-145.11M
FCF Per Share -$0.52
OCF Per Share -$0.41
OCF/S Ratio -8.8%
Income Statement
Revenue $669.5M
Gross Profit $669.5M
Operating Income $-226.44M
EBITDA $-140.33M
Net Income $-319.95M
EPS (Diluted) -$2.24
Revenue / Employee $941.62K
Profit / Employee $-450K
Employees 711
Add to Watchlist
Select watchlists to add or remove ARWR